179 related articles for article (PubMed ID: 14702135)
1. The role of CCK2 receptors in the homeostasis of the opioid system.
Noble F; Roques BP
Drugs Today (Barc); 2003 Nov; 39(11):897-908. PubMed ID: 14702135
[TBL] [Abstract][Full Text] [Related]
2. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.
Roques BP; Noble F
Neurochem Res; 1996 Nov; 21(11):1397-410. PubMed ID: 8947930
[TBL] [Abstract][Full Text] [Related]
3. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.
Pommier B; Beslot F; Simon A; Pophillat M; Matsui T; Dauge V; Roques BP; Noble F
J Neurosci; 2002 Mar; 22(5):2005-11. PubMed ID: 11880531
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
[TBL] [Abstract][Full Text] [Related]
5. Opioids in chronic pain.
Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
[TBL] [Abstract][Full Text] [Related]
6. [Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance].
Benoliel JJ; Becker C; Mauborgne A; Bourgoin S; Hamon M; Cesselin F
Bull Acad Natl Med; 1998; 182(2):311-24. PubMed ID: 9648346
[TBL] [Abstract][Full Text] [Related]
7. Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit.
Micevych PE; Eckersell CB; Brecha N; Holland KL
Brain Res Bull; 1997; 44(4):335-43. PubMed ID: 9370197
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: role of the CCK receptor subtypes 1 and 2.
Malendowicz LK; Spinazzi R; Majchrzak M; Nowak M; Nussdorfer GG; Ziolkowska A; Macchi C; Trejter M
Int J Mol Med; 2003 Dec; 12(6):903-9. PubMed ID: 14612964
[TBL] [Abstract][Full Text] [Related]
9. Opioid-modulating peptides: mechanisms of action.
Mollereau C; Roumy M; Zajac JM
Curr Top Med Chem; 2005; 5(3):341-55. PubMed ID: 15857316
[TBL] [Abstract][Full Text] [Related]
10. Opioid and anti-opioid peptides.
Cesselin F
Fundam Clin Pharmacol; 1995; 9(5):409-33. PubMed ID: 8617406
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.
Quesada A; Micevych P
Brain Res; 2006 Feb; 1073-1074():316-20. PubMed ID: 16472782
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
13. Spinal opioid systems in inflammation.
Stanfa L; Dickenson A
Inflamm Res; 1995 Jun; 44(6):231-41. PubMed ID: 7583517
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
[TBL] [Abstract][Full Text] [Related]
15. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
Maldonado R; Derrien M; Noble F; Roques BP
Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin (CCK) assays.
Trist DG; Corsi M
Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.13. PubMed ID: 21965069
[TBL] [Abstract][Full Text] [Related]
17. Role of opioid ligands in the irritable bowel syndrome.
Corazziari E
Can J Gastroenterol; 1999 Mar; 13 Suppl A():71A-75A. PubMed ID: 10202212
[TBL] [Abstract][Full Text] [Related]
18. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
[TBL] [Abstract][Full Text] [Related]
19. Interactions between cholecystokinin and opioids in the isolated guinea-pig ileum.
Romanelli L; Amico MC; Mattioli F; Morrone LA; Valeri P
Br J Pharmacol; 1999 Jun; 127(4):909-18. PubMed ID: 10433498
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen modulates cholecystokinin: opioid interactions in the nervous system.
Micevych P; Chaban V; Quesada A; Sinchak K
Pharmacol Toxicol; 2002 Dec; 91(6):387-97. PubMed ID: 12688384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
